(Q82161711)
Statements
Serum YKL-40 predicts relapse-free and overall survival in patients with American Joint Committee on Cancer stage I and II melanoma (English)
Henrik Schmidt
Julia S Johansen
Pia Sjoegren
Ib J Christensen
Kirsten Fode
Jorn Larsen
Hans von der Maase